NOF PEG
The PEG Ratio (Price/Earnings-to-Growth) of NOF (4403.T) as of Jul 25, 2026 is 1.71. In the previous year, PEG Ratio (Price/Earnings-to-Growth) was 1.83 — a change of -6.87% (lower).
Get this data via API
Financial Data API
PEG
1.71
YoY
-6.87%
Last updated:
PEG Ratio (Price/Earnings-to-Growth) of NOF is 2026 1.71 . PEG Ratio (Price/Earnings-to-Growth) of NOF was 2025 1.83 . It decreases by -6.87% lower compared to the previous year.
Access this data via the Eulerpool API
NOF Stock analysis
What does NOF do? NOF Corporation is a Japanese company that has been operating in various industries since its establishment in 1911. It started as a manufacturer of chemicals, particularly olefinic derivatives, and soon discovered other sectors. Today, NOF Corp is a major player in the pharmaceutical, life sciences, and materials science industries.
NOF Corp is headquartered in Tokyo and has branches and subsidiaries in various countries. It is listed on the Tokyo Stock Exchange and employs over 2,500 people worldwide.
History:
NOF Corp was founded in 1911 as a trading company specializing in the sale of chemicals. In the 1920s, the company began producing synthetic camphor, an important raw material in the fragrance and medical fields.
During World War II, NOF manufactured military goods, including ammunition, aircraft components, and synthetic fibers. After the war, the company refocused on chemistry and expanded its presence in other countries, particularly in the United States and Europe.
In the 1980s, NOF expanded into new industries such as advertising, marketing, and real estate. Currently, the company focuses on three main business areas: pharmaceuticals, life sciences, and materials science.
Business Model:
NOF Corp is a B2B company that primarily sells its products to other businesses. The company focuses on providing high-quality products tailored to the diverse needs of its customers. One of the company's principles is to constantly develop innovations to offer its customers a high level of quality and performance.
NOF Corp also collaborates closely with companies and universities to advance research and development together. The company invests in research and development activities to offer innovative and effective solutions to its customers.
Divisions:
NOF Corp is divided into three main business segments: pharmaceuticals, life sciences, and materials science.
Pharmaceuticals:
NOF Corp produces a variety of pharmaceutical products, including active ingredients, intermediates, and excipients. These products are used by pharmaceutical companies worldwide to manufacture a wide range of drugs.
Life Sciences:
NOF Corp produces high-quality biochemicals and accessories to support cell growth in biotechnology and life sciences research. The company also manufactures polyethylene glycol-based products that are widely used in the pharmaceutical and life sciences industries.
Materials Science:
NOF Corp produces and supplies a range of materials, including electronic materials, polymers, separation membranes, and specialty resins. These materials are used in various industries such as electronics, automotive manufacturing, and energy supply.
Products:
NOF Corp offers a wide range of products, including:
- Pharmaceutical active ingredients: NOF Corp manufactures active ingredients used in various medications.
- Biochemicals: NOF Corp supplies chemical products used in cell culture in the life sciences industry.
- Electronic materials: The company produces a range of high-tech materials used in the electronics industry.
- Specialty resins: NOF Corp produces resins used in various areas such as the automotive industry and pipe manufacturing.
- Separation membranes: NOF Corp offers membranes used in water treatment, wastewater treatment, and chemical separation.
In summary, NOF Corp is a versatile company that manufactures a wide range of products in the pharmaceutical, life sciences, and materials science fields. The company has a long history and is committed to developing innovations to provide its customers with innovative solutions and high-quality products. NOF is one of the most popular companies on Eulerpool.
Frequently Asked Questions about NOF stock
PEG Ratio (Price/Earnings-to-Growth) of NOF is 1.71 in 2026.
Access this data via the Eulerpool API
Valuation — NOF
All Key Metrics — NOF
Valuation
Income Statement
Margins
Balance Sheet
- Total Assets
- Current Assets
- Cash & Equivalents
- Receivables
- Inventory
- Property, Plant & Equipment
- Goodwill
- Intangible Assets
- Equity
- Liabilities
- Debt
- Current Liabilities
- Long-term Debt
- Short-term Debt
- Retained Earnings
- Book Value per Share
- Tangible Book Value per Share
- Working Capital
- Investments
- Accounts Payable
- Non-Current Assets
- Short-Term Investments
- Long-Term Investments
- Net Debt
- Treasury Stock
- Minority Interest
- Deferred Tax Liabilities
- Net Tangible Assets
- Goodwill/Assets
- Intangibles/Assets
Cash Flow
- Operating Cash Flow
- Capital Expenditures
- Free Cash Flow
- FCF per Share
- Dividends Paid
- Share Buybacks
- Investing Cash Flow
- Financing Cash Flow
- CapEx / Revenue
- Cash Flow per Share
- Stock-Based Compensation
- Change in Working Capital
- Acquisitions (Net)
- Net Change in Cash
- CapEx/OCF
- FCF/Net Income
- FCF Conversion
- Cash Conversion
- Total Shareholder Payout
- CapEx/D&A
Profitability
- ROE
- ROA
- ROCE
- ROIC
- Asset Turnover
- Inventory Turnover
- Receivables Turnover
- Days Sales Outstanding
- Days Inventory Outstanding
- Days Payable Outstanding
- Cash Conversion Cycle
- CROIC
- Gross Profit/Assets
- Fixed Asset Turnover
- Equity Turnover
- Working Capital Turnover
- Payables Turnover
- Capital Intensity
- Receivables/Revenue
- Inventory/Revenue
- EBIT/Assets
Leverage
Growth
- Revenue Growth
- Revenue CAGR 3Y
- Revenue CAGR 5Y
- Revenue CAGR 10Y
- Earnings Growth
- EPS Growth
- EBIT Growth
- EBIT CAGR 3Y
- EBIT CAGR 5Y
- EBIT CAGR 10Y
- Dividend Growth
- FCF Growth
- Book Value Growth
- Earnings CAGR 3Y
- Earnings CAGR 5Y
- Earnings CAGR 10Y
- EPS CAGR 3Y
- EPS CAGR 5Y
- EBITDA Growth YoY
- EBITDA CAGR 3Y
- EBITDA CAGR 5Y
- Gross Profit Growth
- OCF Growth YoY
- Employee Growth
- Dividend CAGR 3Y
- Dividend CAGR 5Y
- Dividend CAGR 10Y
- Asset Growth
- Equity Growth
- Debt Growth
- CapEx Growth
- FCF CAGR 3Y
- FCF CAGR 5Y
- Market Cap Growth
- Share Count Growth